Page last updated: 2024-08-24

cr 1392 and lorglumide

cr 1392 has been researched along with lorglumide in 2 studies

*lorglumide: RN given refers to (+-)-isomer [MeSH]

*lorglumide: RN given refers to (+-)-isomer [MeSH]

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baba, S; Fujii, M; Fujisawa, T; Hasegawa, H; Koide, M; Nakamura, T; Okabayashi, Y; Otsuki, M; Tani, S1
Bani, M; Chisté, R; Makovec, F; Revel, L; Rovati, LA; Rovati, LC1

Other Studies

2 other study(ies) available for cr 1392 and lorglumide

ArticleYear
Proglumide analogues CR 1409 and CR 1392 inhibit cholecystokinin-stimulated insulin release more potently than exocrine secretion from the isolated perfused rat pancreas.
    Pancreas, 1990, Volume: 5, Issue:3

    Topics: Animals; Cholecystokinin; Glutamine; In Vitro Techniques; Insulin; Insulin Secretion; Islets of Langerhans; Male; Pancreas; Proglumide; Radioimmunoassay; Rats; Rats, Inbred Strains

1990
Differentiation of central and peripheral cholecystokinin receptors by new glutaramic acid derivatives with cholecystokinin-antagonistic activity.
    Arzneimittel-Forschung, 1986, Volume: 36, Issue:1

    Topics: Animals; Benzamides; Cerebral Cortex; In Vitro Techniques; Kinetics; Male; Mice; Pancreas; Proglumide; Rats; Receptors, Cell Surface; Receptors, Cholecystokinin; Sincalide; Tetragastrin

1986